• Wion
  • /Videos
  • /Pancreatic Cancer Breakthrough? Personalised mRNA Vaccine Shows Long-Term Survival In Early Trial

Pancreatic Cancer Breakthrough? Personalised mRNA Vaccine Shows Long-Term Survival In Early Trial

A new personalised mRNA vaccine is offering fresh hope in the fight against pancreatic cancer—one of the hardest cancers to treat. In an early-stage trial, patients who responded to the vaccine showed long-term survival, with many living beyond six years after treatment. The vaccine is tailored to each patient following surgery, helping the immune system target cancer cells more effectively. While still in early stages, this approach could mark a major shift in how aggressive cancers are treated.